Page last updated: 2024-08-25

bendamustine hydrochloride and Cardiomyopathies

bendamustine hydrochloride has been researched along with Cardiomyopathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dhande, P; Girkar, N; Pawar, S; Zaki, S1
Boruchov, A; Mulay, S1

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Cardiomyopathies

ArticleYear
Reversible Cardiomyopathy after Rituximab Treatment in a Chronic Lymphocytic Leukemia Patient.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cardiomyopathies; Cough; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Rituximab

2022
Recurrent and partially reversible cardiomyopathy occurring during treatment with bendamustine and rituximab.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cardiomyopathies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Count; Male; Rituximab

2015